Bactiguard Holding Ab · OMXSTO:BACTI_B
Bactiguard Holding Ab — Q1 2023 Earnings Presentation
14 slides from Bactiguard Holding Ab's earnings presentation, Apr 27, 2023
Slide 1: Q1 report 2023 presentation
Q1 report 2023 presentation Thursday April 27, 2023 Anders Göransson, CEO Carin Jakobson, CFO
Slide 2: Prevention, HAI and AMR gaining awareness and attention
Prevention, HAI and AMR gaining awareness and attention Swedish evening news reports on significant investments in cleaner air in hospital High-level meeting on antimicrobial resistance (AMR) – prevention one of three themes Draft of “People-centred framework for addressing antimicrobial resistance
Slide 3: Opportunities behind critical global healthcare trends
Opportunities behind critical global healthcare trends Vision: to champion a healthier world by preventing infections The issues The USD 80bn market opportunity Orthopedics 40 • Rise of infections, increased antibiotics use and development of multi-resistant bacteria a threat to global health and mo
Slide 4: Q1 2023: Continued focus on growth and transformation
Q1 2023: Continued focus on growth and transformation
Slide 5: Financials Q1 2023 (Q1 2022) and key events
Financials Q1 2023 (Q1 2022) and key events Continued focus on growth and transformation Revenues EBITDA Net Loss Operating cash flow 61 (55) MSEK -6.6 (-4.0) MSEK -22.1 (-16.5) MSEK -8.8 (-12.9) MSEK Key events • Mikael Sander appointed Head of Bactiguard Product Portfolio BIP, joins Bactiguard’s m
Slide 6: Financial overview
Financial overview • Total revenue increase of 11% Amounts in TSEK 2023 2022 Jan-March Jan-March • License 8% • BPP 6% Total revenues 61.2 55.2 - License 39.4 36.4 • EBITDA continues to be - BPP 16.3 15.4 impacted by investments in line EBITDA -6.6 -4.0 with the growth strategy EBITDA margin % -10.8
Slide 7: Rolling 12-month revenues
Rolling 12-month revenues Strong overall momentum – rolling RTM development, MSEK 12-month revenues all-time high 80,0 250 60,0 • Blue bar license revenues – key 200 driver is BD and initial contributions from Zimmer Biomet (trauma) 40,0 150 • Yellow bar new license revenues – good momentum in both
Slide 8: Q1 2023 highlights – License business
Q1 2023 highlights – License business License New licenses Revenues Q1 2023 Revenues Q1 2023 36.3 (31.2) MSEK 3.1 (5.2) MSEK +16%* -40%* Orthopedics (trauma) Orthopedics (broader portfolio) • Progressing according to plan • Progressing according to plan, • Largest license partner • ZNN Bactiguard re
Slide 9: Q1 2023 highlights – Bactiguard product portfolio
Q1 2023 highlights – Bactiguard product portfolio BACTIGUARD PRODUCT PORTFOLIO (BPP) Mikael Sander new Head of Bactiguard Product Portfolio • Focus on operational excellence and increased profitability Revenues Q1 2023 16.3 (15.4) MSEK Sales increase by modest 6% +6%* • Good momentum in the Nordics
Slide 10: Operating cash flow and liquidity
Operating cash flow and liquidity Cash flow and liquidity, MSEK • Strong financial position 300 40 enabling investments to drive growth 250 30 • Available liquidity incl. overdraft 200 20 facility 217 (232) MSEK • Cash flow from operating Cash flow Liquidity 150 10 activities Q1 -7.7 (-11.9) MSEK 10
Slide 11: Key priorities 2023
Key priorities 2023 Continued focus on growth and transformation Strengthen Technology – BPP – license business – drive and develop operational excellence current and new partners coating, current and new US go-to-market Continued focus on strategy FDA-approvals 11
Slide 12: Drivers to deliver growth and profitability
Drivers to deliver growth and profitability The need for infection prevention has never been greater Illustrative M&A Financial targets 2026 Revenues >1 billion SEK EBITDA >400 million SEK * Today Orthopedics (broader portfolio) Existing license customers Orthopedics (trauma) 12 * Currently a global
Slide 13: Q&A
Q&A Q&A to champion a healthier world by preventing infections 13
Slide 14: Questions & Answers
Questions & Answers Anders Göransson Carin Jakobson CEO CFO anders.goransson@bactiguard.com carin.jakobson@bactiguard.com 14